Biotechnology-derived cardiovascular therapeutics and toxicity

By James Y.  

Cardiovascular Toxicology, Vol. 3, Iss. 1, 2003-03 ,pp. : 1-3

Humana Press, Inc

Access to resources Recommend Favorite

Commercial Development and Application of Type A Lantibiotics

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 175-185

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Targeting Agents: Therapeutics and Diagnostic Development

By  

Angiogenesis, Vol. 7, Iss. 2, 2004-01 ,pp. : 189-189

Springer Publishing Company

Access to resources Recommend Favorite

The Use of Frozen-Thawed Platelet-Derived Phospholipids as a Confirmatory Test for the Diagnosis of Lupus Anticoagulants. Comparison with Two Commercial Confirmatory System Tests

By Cappucci G.   Grandone E.   Giuliani N.   Margaglione M.   Di Minno G.  

Thrombosis Research, Vol. 94, Iss. 6, 1999-06 ,pp. : 373-380

Elsevier

Access to resources Recommend Favorite

Carbohydrates in Therapeutics

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 3, 2007-07 ,pp. : 186-197

Bentham Science Publishers

Access to resources Recommend Favorite